Logo image of ARAY

ACCURAY INC (ARAY) Stock Overview

USA - NASDAQ:ARAY - US0043971052 - Common Stock

1.61 USD
0 (0%)
Last: 10/22/2025, 4:19:49 PM
1.61 USD
0 (0%)
After Hours: 10/22/2025, 4:19:49 PM

ARAY Key Statistics, Chart & Performance

Key Statistics
Market Cap181.48M
Revenue(TTM)458.50M
Net Income(TTM)-1591000
Shares112.72M
Float109.33M
52 Week High2.95
52 Week Low1.14
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.03
PEN/A
Fwd PEN/A
Earnings (Next)10-29 2025-10-29
IPO2007-02-08
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


ARAY short term performance overview.The bars show the price performance of ARAY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 15

ARAY long term performance overview.The bars show the price performance of ARAY in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of ARAY is 1.61 USD. In the past month the price decreased by -6.4%. In the past year, price decreased by -8%.

ACCURAY INC / ARAY Daily stock chart

ARAY Latest News, Press Relases and Analysis

ARAY Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.64 222.69B
ISRG INTUITIVE SURGICAL INC 61.21 188.93B
BSX BOSTON SCIENTIFIC CORP 36.7 153.88B
SYK STRYKER CORP 30.22 148.47B
MDT MEDTRONIC PLC 17.34 123.01B
BDX BECTON DICKINSON AND CO 13.18 53.92B
IDXX IDEXX LABORATORIES INC 52.77 50.70B
EW EDWARDS LIFESCIENCES CORP 29.9 45.11B
RMD RESMED INC 27.9 38.89B
GEHC GE HEALTHCARE TECHNOLOGY 16.34 34.76B
DXCM DEXCOM INC 41.59 27.73B
PHG KONINKLIJKE PHILIPS NVR- NY 17.11 27.51B

About ARAY

Company Profile

ARAY logo image Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

Company Info

ACCURAY INC

1240 Deming Way

Madison WISCONSIN 94089 US

CEO: Joshua H. Levine

Employees: 987

ARAY Company Website

ARAY Investor Relations

Phone: 16088242800

ACCURAY INC / ARAY FAQ

What is the stock price of ACCURAY INC today?

The current stock price of ARAY is 1.61 USD.


What is the ticker symbol for ACCURAY INC stock?

The exchange symbol of ACCURAY INC is ARAY and it is listed on the Nasdaq exchange.


On which exchange is ARAY stock listed?

ARAY stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ACCURAY INC stock?

10 analysts have analysed ARAY and the average price target is 5.61 USD. This implies a price increase of 248.45% is expected in the next year compared to the current price of 1.61. Check the ACCURAY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ACCURAY INC worth?

ACCURAY INC (ARAY) has a market capitalization of 181.48M USD. This makes ARAY a Micro Cap stock.


How many employees does ACCURAY INC have?

ACCURAY INC (ARAY) currently has 987 employees.


What are the support and resistance levels for ACCURAY INC (ARAY) stock?

ACCURAY INC (ARAY) has a support level at 1.56 and a resistance level at 1.62. Check the full technical report for a detailed analysis of ARAY support and resistance levels.


Is ACCURAY INC (ARAY) expected to grow?

The Revenue of ACCURAY INC (ARAY) is expected to grow by 4.49% in the next year. Check the estimates tab for more information on the ARAY EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ACCURAY INC (ARAY) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ACCURAY INC (ARAY) stock pay dividends?

ARAY does not pay a dividend.


When does ACCURAY INC (ARAY) report earnings?

ACCURAY INC (ARAY) will report earnings on 2025-10-29.


What is the Price/Earnings (PE) ratio of ACCURAY INC (ARAY)?

ACCURAY INC (ARAY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).


What is the Short Interest ratio of ACCURAY INC (ARAY) stock?

The outstanding short interest for ACCURAY INC (ARAY) is 2.78% of its float. Check the ownership tab for more information on the ARAY short interest.


ARAY Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to ARAY. When comparing the yearly performance of all stocks, ARAY turns out to be only a medium performer in the overall market: it outperformed 55.8% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ARAY Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ARAY. ARAY may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ARAY Financial Highlights

Over the last trailing twelve months ARAY reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 81.88% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.34%
ROE -1.96%
Debt/Equity 1.53
Chartmill High Growth Momentum
EPS Q2Q%-96.67%
Sales Q2Q%-5.02%
EPS 1Y (TTM)81.88%
Revenue 1Y (TTM)2.68%

ARAY Forecast & Estimates

10 analysts have analysed ARAY and the average price target is 5.61 USD. This implies a price increase of 248.45% is expected in the next year compared to the current price of 1.61.

For the next year, analysts expect an EPS growth of -5.52% and a revenue growth 4.49% for ARAY


Analysts
Analysts86
Price Target5.61 (248.45%)
EPS Next Y-5.52%
Revenue Next Year4.49%

ARAY Ownership

Ownership
Inst Owners71.34%
Ins Owners1.77%
Short Float %2.78%
Short Ratio3.97